| Ytd | -36.50% | |
| 1y | 18.24% |
| Open | 10.85 | Prev Close | 10.85 | Low | 10.42 | High | 11.01 | Mkt Cap | 840.23M |
| Vol | 901.34K | Avg Vol | 1.19M | EPS | -2.09 | P/E | N/A | Forward P/E | 7.60 |
| Beta | 0.61 | Short Ratio | 9.36 | Inst. Own | 83.10% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 04-30 | 50-d Avg | 11.16 | 200-d Avg | 12.70 | 1yr Est | 23.70 |
Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT), a biopharmaceutical company focused on developing and c
HC Wainwright & Co. analyst Matthew Caufield reiterates Phathom Pharmaceuticals (NASDAQ:PHAT)
Phathom Pharmaceuticals (NASDAQ:PHAT) affirms FY2026 sales outlook from $320.000 million-$345.000 mi
Phathom Pharmaceuticals (NASDAQ:PHAT) reported quarterly losses of $(0.18) per share which beat the
Top Wall Street analysts upgraded PHAT and PWR, while AGX was upgraded to Overweight with a $550 pri
Barclays analyst Glen Santangelo upgrades Phathom Pharmaceuticals (NASDAQ:PHAT) from Equal-Weight
Guggenheim analyst Yatin Suneja maintains Phathom Pharmaceuticals (NASDAQ:PHAT) with a Buy and ra
Phathom Pharmaceuticals (NASDAQ:PHAT) sees FY2026 sales of $320.000 million-$345.000 million vs $314
Phathom Pharmaceuticals (NASDAQ:PHAT) reported quarterly losses of $(0.08) per share which beat the
Phathom Pharmaceuticals (NASDAQ: PHAT) reported Q4 sales of $57-$58 million, updated FY2025 revenue
(Editor’s note: The future prices of benchmark tracking ETFs and the headline were updated in the st
Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT), a biopharmaceutical company focused on developing and c
Common StockPreferred StockDebt SecuritiesWarrantsUnitsWe may offer and sell the securities identifi
Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earning
U.S. stocks were mostly lower, with the Nasdaq Composite falling more than 200 points on Tuesday.
On Friday, 469 companies hit new 52-week lows.
Gainers SeqLL Inc. (NASDAQ: SQL) shares jumped 120% to $1.85 after dropping around 39% on Thursda
U.S. stock futures traded higher this morning. Here are some big stocks recording losses in today’s
Biopharma stocks were not immune to the broader market downturn seen for much of 2022.
Upgrades
Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) gained 60.1% to settle at $7.27 on Tuesday af
U.S. stocks pared losses midway through trading, with the S&P 500 and Nasdaq Composite turning h
During Monday's trading, 1214 companies set new 52-week lows.
Gainers
During Tuesday's session, 454 stocks hit new 52-week lows.
On Monday, 671 companies achieved new lows for the year.
Tuesday morning saw 454 companies set new 52-week lows.
During Friday's session, 445 companies made new 52-week lows.
On Thursday, 615 stocks hit new 52-week lows.
Gainers Urban One, Inc. (NASDAQ: UONE) shares jumped 255.4% to close at $6.54 on Monday after su
Gainers Fuel Tech, Inc (NASDAQ: FTEK) shares climbed 93.6% to close at $0.91 on Friday after the
77 Biggest Movers From Yesterday